CHROMADEX INC.;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人:
BARTOS, JEREMY,DELLINGER, RYAN
申请号:
EP12876092
公开号:
EP2846785A4
申请日:
2012.11.14
申请国别(地区):
EP
年份:
2016
代理人:
摘要:
A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene.